Mark Mongiardo can get drunk really easily — and it’s not because he’s a lightweight. In fact, the 43-year-old dad gave up alcohol entirely in 2018, but he can still get buzzed, tipsy and even fully ...

Big changes could be coming to the concert and live entertainment industry. On Wednesday, a jury found Live Nation and Ticketmaster liable for operating as a monopoly, marking one of the most ...

A jury found Live Nation and its subsidiary Ticketmaster are a monopoly in violation of federal and state laws. The trial could have implications for both the company and the entertainment industry.

States expected to seek Ticketmaster-Live Nation breakup Live Nation monopolized concert ticketing, amphitheater markets, jury finds Penalties and damages to be determined through future proceedings ...

A jury found Live Nation and Ticketmaster operated as a monopoly in its dominance of the live events and ticketing industry, validating complaints that the industry giant was stifling competition and ...

NEW YORK -- A jury has found that concert giant Live Nation and its Ticketmaster subsidiary had a harmful monopoly over big concert venues, dealing the company a loss in a lawsuit over claims brought ...

AUGUSTA, Ga. -- The 2026 Masters has officially arrived with four days of pristine golf at the country's best course getting underway as all 91 men in the star-studded Masters field aim to complete 72 ...

View post: The Race for the Ultimate FIFA World Cup Liquor Has Officially Started. See All the New Limited-Edition Expressions “Why is the rum always gone?” It’s a recurring question posed by Captain ...

Share on Pinterest Kim Kardashian has released a new energy drink with paraxanthine instead of caffeine. Image credit: Axelle/Bauer-Griffin/Getty Images Kim Kardashian has launched a new energy drink ...

A nostalgic juice option that has been in stores since 1946 is going the way of the dodo. The Coca-Cola Company announced last month that it is discontinuing Minute Maid frozen juice concentrates in ...

This single-arm phase II study evaluated savolitinib and durvalumab in treatment-naïve or pretreated PRC. End points included overall response rate (ORR), progression-free survival (PFS), and overall ...